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Abstract. 
 
Bone development requires the recruitment
of osteoclast precursors from surrounding mesen-
chyme, thereby allowing the key events of bone growth
such as marrow cavity formation, capillary invasion,
and matrix remodeling. We demonstrate that mice deﬁ-
cient in gelatinase B/matrix metalloproteinase (MMP)-9
exhibit a delay in osteoclast recruitment. Histological
analysis and specialized invasion and bone resorption
models show that MMP-9 is speciﬁcally required for the
invasion of osteoclasts and endothelial cells into the
discontinuously mineralized hypertrophic cartilage that
ﬁlls the core of the diaphysis. However, MMPs other
than MMP-9 are required for the passage of the cells
through unmineralized type I collagen of the nascent
bone collar, and play a role in resorption of mineralized
matrix. MMP-9 stimulates the solubilization of unmin-
eralized cartilage by MMP-13, a collagenase highly ex-
pressed in hypertrophic cartilage before osteoclast in-
vasion. Hypertrophic cartilage also expresses vascular
endothelial growth factor (VEGF), which binds to ex-
tracellular matrix and is made bioavailable by MMP-9
(Bergers, G., R. Brekken, G. McMahon, T.H. Vu, T.
Itoh, K. Tamaki, K. Tanzawa, P. Thorpe, S. Itohara, Z.
 
Werb, and D. Hanahan. 2000. 
 
Nat. Cell Biol.
 
 2:737–744).
We show that VEGF is a chemoattractant for osteo-
clasts. Moreover, invasion of osteoclasts into the hyper-
trophic cartilage requires VEGF because it is inhibited
by blocking VEGF function. These observations iden-
tify speciﬁc actions of MMP-9 and VEGF that are criti-
cal for early bone development.
 
Key words: matrix metalloproteinase • VEGF • osteo-
clast recruitment • endothelial cell • bone development
 
Introduction
 
Bone resorption is essential for the development and
maintenance of the skeleton. The main cell responsible for
this process is the osteoclast. In embryonic long bones, os-
teoclasts appear in bone at an early developmental stage
(Scheven et al., 1986; Blavier and Delaissé, 1995). First,
mononucleated osteoclast precursors enter the mesen-
chyme surrounding the bone rudiments, proliferate, differ-
entiate into tartrate-resistant acid phosphatase (TRAP)
 
1
 
-
positive cells, and migrate together with endothelial cells
through the nascent bone collar. Then, they invade the cal-
cified cartilage, filling the core of the diaphysis while fus-
ing and differentiating into mature osteoclasts, and trans-
form the core of the bone into a marrow cavity.
The molecular mechanisms directing osteoclastic re-
sorptive activity to specific areas of the bone have gener-
ated much interest. Osteoclasts are generated from he-
matopoietic stem cells under the control of several
systemic and local factors (Hofbauer et al., 2000). Osteo-
clast differentiation factor (Kong et al., 1999), osteoprote-
 
gerin (Simonet et al., 1997), macrophage colony-stimulating
factor (M-CSF) (Felix et al., 1990; Wiktor-Jedrzejczak et
al., 1990; Yoshida et al., 1990), vascular endothelial
growth factor (VEGF) (Niida et al., 1999), interleukin-1
(Jimi et al., 1999), and tumor necrosis factor-
 
a
 
 (Kobayashi
et al., 2000) are involved in osteoclast differentiation.
TGF-
 
b
 
 (Dieudonné et al., 1991; Zheng et al., 1994),
M-CSF (Fuller et al., 1993), hepatocyte growth factor
(Fuller et al., 1995a), interleukin-8 and macrophage inflam-
matory protein-1
 
a
 
 (Fuller et al., 1995b), C3 component of
complement (Mangham et al., 1993), osteopontin (Faccio
et al., 1998; Terai et al., 1999), and bone sialoprotein (Raynal
et al., 1996) help target the resorptive activity of osteo-
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clasts to specific sites of the matrix. In addition, protein-
ases of the matrix metalloproteinase (MMP) family are
indispensable for the recruitment of osteoclasts in devel-
oping metatarsals (Blavier and Delaissé, 1995), and this
role is distinct from synergy with cysteine proteinases in sol-
ubilizing calcified matrix in the resorption zone (Everts et
al., 1998; Saftig et al., 1998). The specific MMP(s) responsi-
ble for these osteoclastic activities, and its (their) mode of
action have not been determined (Delaissé et al., 2000).
MMP-9 is a candidate for regulating these functions be-
cause it is highly expressed in osteoclasts (for review see
Vu and Werb, 1998). In embryonic bone, before the for-
mation of the marrow cavity, MMP-9 is highly expressed
in cells in the mesenchyme surrounding bone rudiments;
as the marrow cavity develops, MMP-9 expression is de-
tected in osteoclasts in the core of the diaphysis (Reponen
et al., 1994; Blavier and Delaissé, 1995; Jemtland et al.,
1998). Subsequently, the marrow cavity expands longitu-
dinally and at either end interacts with the epiphyseal area
to form the growth plates and the metaphysis, areas that
are very critical for bone growth and (re)modelling.
MMP-9 is then expressed in typical (TRAP
 
1
 
) osteoclasts
localized along the mineralized longitudinal septae of the
metaphysis, as well as in osteoclast-like cells that are lo-
calized next to the nonmineralized transverse septae that
separate them from the last row of hypertrophic chondro-
cytes (Jemtland et al., 1998; Vu et al., 1998). This is exactly
at the invasion front of the growth plates, where endothe-
lial cells are also abundant. Because these cells are local-
ized against cartilage and differ from osteoclasts to some
extent, they are sometimes called chondroclasts. Impor-
tantly, the histology of MMP-9 null mice shows that it is a
key proteinase for the invasion of the growth plate, but
does not support a role of MMP-9 in the actual solubili-
zation of mineralized matrix by osteoclasts (Vu et al.,
1998). In addition, a study combining in situ zymography,
MMP-9 antagonists, and immunohistochemistry showed
that MMP-9 acts on the nonmineralized transverse septae
of the growth plate (Lee et al., 1999). It is not clear
whether MMP-9 exerts a simple mechanical role, such as
solubilizing the transversal septae, or plays a more subtle
role, such as generating signals that render the cells inva-
sive. Indeed, there are strong indications that MMP-9 ex-
erts its role in invasion of the growth plate through the re-
lease of molecules sequestered in the extracellular matrix
(Vu et al., 1998). VEGF is one such molecule, since block-
ing its function leads to impaired invasion of the growth
plate, mimicking the phenotype of MMP-9–negative bones
(Gerber et al., 1999).
In this study, we analyzed metatarsals of MMP-9–neg-
ative and MMP-9–positive embryos well before the for-
mation of the growth plate, and found that the recruit-
ment of the very first osteoclasts in these bones is
affected by lack of MMP-9. By using a combination of
histological analysis, bone resorption models, invasion
chamber experiments, and MMP and VEGF antagonists,
we show that the role of MMP-9 in this process is clearly
distinct from the role other MMPs play in other steps of
bone development. MMP-9 specifically regulates pro-
teolysis of nonmineralized cartilage and release of ECM-
bound VEGF, exerting direct chemotactic activity on os-
teoclasts.
 
Materials and Methods
 
Mice and Reagents
 
All animal experiments were performed according to approved protocols
following institutional guidelines at the Center for Clinical and Basic Re-
search, the Finsen Laboratory, and the University of California at San
Francisco. Mouse embryos for the bone resorption models were litter-
mates from MMP-9
 
1
 
/
 
2 
 
parents, backcrossed to C57B1/6J for two genera-
tions. Mouse embryos for the histomorphometry study were littermates
from MMP-9
 
1
 
/
 
2 
 
3 
 
MMP-9
 
2/2
 
 parents. The mating times were within a 4-h
period. The phenotype of each mouse was determined by gelatin zymog-
raphy of calvarial extracts (Eeckhout et al., 1986) and their genotype by
PCR analysis of tail DNA. The wild-type gelatinase B allele was detected
by PCR with wild-type primers wt-1 (5
 
9
 
-GCA TAC TTG TAC CGC TAT
GG-3
 
9
 
)
 
 
 
and wt-2 (5
 
9
 
-TAA CCG AGG TGC AAA CTG G-3
 
9
 
). These
primers generate a 300-bp fragment. The targeted gelatinase B allele was
detected using two primers complementary to the neomycin resistance
gene, Neo-1 (5
 
9
 
-ATG ATT GAA CAA GAT GGA TTG CAC G-3
 
9
 
) and
Neo-2 (5
 
9
 
-TTC GTC CAG ATC ATC CTG ATC GAC-3
 
9
 
). Together
these primers generate a 480 bp-fragment. Investigations of MMP-9 ex-
pression during development (in situ hybridization, immunohistochemis-
try, and zymography) were done in NMRI strain mice.
Rabbit anti–human MMP-9 antibody (Nielsen et al., 1997) was a gift
from Dr. B.S. Nielsen and Dr. N. Borregaard (Finsen Laboratory and Rigs-
hospitalet, Copenhagen). Rat anti–mouse CD34 antibody (Garlanda et
al., 1997) was a gift from Dr. C. Garlanda (Pharmacology Institute Mario
Negri, Milan, Italy). Recombinant human MMP-13 was a gift from Dr. C.
Lopez-Otin (University of Oviedo, Oviedo, Spain). MMP-9 was purified
to homogeneity from cultures of BHK cells transfected with mouse MMP-9
and provided by Dr. M. Ferreras (Center for Clinical and Basic Re-
search). Recombinant human VEGF and recombinant human Flt-1/Fc
chimera were provided by R&D Systems. Recombinant mouse mFlt-IgG
chimera was a gift from Dr. Napoleone Ferrara (Genentech, Inc., San
Francisco, CA). GM6001, a general MMP inhibitor, was from AMS Scien-
tific. The other reagents were from suppliers described previously (De-
laissé et al., 1985; Blavier and Delaissé, 1995; Sato et al., 1998).
 
Analysis of MMPs by Zymography
 
Calvariae and tibiae were extracted as described (Eeckhout et al., 1986) in a
buffer containing 10 mM cacodylate-HCl, pH 6, 1 M NaCl, 0.1 mg/ml Triton
X-100, 0.2 mg/ml NaN
 
3
 
, 10
 
2
 
6
 
 M ZnCl
 
2
 
. The two metatarsal triads of each
embryo were extracted together in 500 
 
m
 
l extraction buffer for 24 h, and ex-
tracts were concentrated four to five times, before analysis by zymography
(Lefebvre et al., 1991). To determine whether there were compensatory
changes in other proteolytic activities in the absence of MMP-9, a variety of
zymography conditions were used: gelatin and casein as substrate, 7.5–12%
acrylamide concentrations, and incubation times of 18–60 h.
 
Bone Resorption Models
 
Bone resorption was evaluated with well established models (Delaissé et
al., 1985; Blavier and Delaissé, 1995), on littermates of heterozygote par-
ents. Timed pregnant mothers were injected at day 16 (day of vaginal plug
discovery is designated day 0) with 100 
 
m
 
Ci 
 
45
 
Ca. The middle three meta-
tarsals and the tibiae were isolated at day 17, and calvariae were isolated
at day 18. The middle three metatarsals were kept together as triads. The
bone explants were placed on filter paper floating on 400 
 
m
 
l culture me-
dium in 24-well plates. The medium consisted of BGJb solution supple-
mented with ascorbate (50 
 
m
 
g/ml), glutamax (500 
 
m
 
g/ml), and albumax (1
mg/ml). In addition, the media for long bones were supplemented with
1,25(OH)
 
2
 
D
 
3
 
 (10
 
2
 
8 
 
M) (Blavier and Delaissé, 1995), and those for calva-
riae with parathyroid hormones (2 
 
3
 
 10
 
2
 
8 
 
M) (Delaissé et al., 1985). Cul-
tures lasted usually for 4 d. We measured the 
 
45
 
Ca released every day in
the media and that left in the tissue at the end of the culture. The deminer-
alization of the bone explants during the cultures was then expressed cu-
mulatively as percentage of total amount of radioactivity. The release of
 
45
 
Ca from paired experimental groups was compared by the analysis of
variance for multiple comparisons.
 
Histomorphometry
 
Metatarsal triads (consisting of the middle three metatarsals) were ob-
tained from littermates of MMP-9
 
1
 
/
 
2
 
 
 
3
 
 MMP-9
 
2
 
/
 
2
 
 parents. Histological 
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procedures, the histochemical method for TRAP staining, and the deter-
mination of numbers and distributions of TRAP
 
1
 
 cells and of their nuclei
in longitudinal sections of the diaphysis were performed as described pre-
viously (Blavier and Delaissé, 1995). These analyses were performed by
an investigator unaware of the genotype. Cells and their nuclei were
scored as “in” upon their invasion into the calcified cartilage filling the
core of the diaphysis, thus indicating their ability to invade. For each
metatarsal triad, countings were typically performed in five sections at 20
 
m
 
m from each other and the mean of these five counts was calculated. The
results were expressed as mean number of cells or nuclei in one section of
metatarsal triad. Counts in 
 
1/2
 
 and 
 
2/2
 
 bones were compared by using
the analysis of variance. The analysis of cell and nucleus counts has always
led to the same conclusions concerning invasion; however, for clarity, the
illustrations in this work show only counts of nuclei because they are more
representative of a process where new mononucleated cells are generated
and progressively undergo fusion to multinucleated cells.
 
Immunohistochemistry
 
Paraffin sections were treated with 0.45% H
 
2
 
O
 
2
 
 in ethanol to inactivate
endogenous peroxidase. For detection of CD34, the sections were di-
gested with trypsin, blocked with casein, incubated overnight with a 1:100
dilution of anti-CD34 antibody, and treated successively with a 1:20 dilu-
tion of biotinylated anti–rat antibody and peroxidase-conjugated extravi-
din. For detection of MMP-9 (Nielsen et al., 1997), the sections were
treated three times for 5 min in 10 mM Tris/1 mM EDTA, pH 9, in a mi-
crowave oven, blocked with BSA and 0.5% Triton, incubated overnight
with a 1:400 dilution of anti–MMP-9 antibody, and finally reacted for 30
min with Dako EnVision™
 
1
 
 (Peroxidase, Rabbit, K4003). The CD34 and
MMP-9 immunoreactivity was visualized by developing the slides in DAB,
and H
 
2
 
O
 
2
 
 control MMP-9 immunostainings performed on MMP-9–defi-
cient bones were negative. When CD34 immunostaining and TRAP activ-
ity staining were performed on the same sections, immunostainings were
done first, followed by TRAP histochemistry. Sections were counter-
stained with Erlich’s hematoxylin.
 
In Situ Hybridization
 
In situ hybridizations were performed on paraffin sections as reported
(Graber et al., 1995). A fragment of the 3
 
9
 
 end of mouse MMP-9 cDNA
overlapping the stop codon (1633–1913) was subcloned into CR11-TOPO
cloning vector (Invitrogen), and antisense and sense digoxygenin-labeled
riboprobes (of 281 bp) were prepared with SP6 and T7 by using an RNA
labeling kit (Boehringer). The hybridized probe was detected by using al-
kaline phosphatase–conjugated antidigoxygenin antibody and NBT–BCIP
substrate mix (Boehringer). The sections were counterstained with meth-
ylene blue. For localization of VEGF expression, 
 
35
 
S-labeled antisense
probes were prepared and used as described previously (Gerber et al.,
1999).
 
Invasion and Chemotaxis Assay
 
For invasion experiments with MMP-9–positive
 
 
 
and MMP-9–negative os-
teoclasts, osteoclasts were generated from marrow of MMP-9
 
1
 
/
 
1
 
 and
MMP-9
 
2
 
/
 
2
 
 mice, cultured in the presence of M-CSF and osteoclast differ-
entiation factor (Lacey et al., 1998). For VEGF chemotaxis experiments,
osteoclasts were generated from marrow of NMRI mice, cocultured with
primary osteoblasts in the presence of 1,25(OH)
 
2
 
D
 
3
 
 (Akatsu et al., 1992).
They were detached by sequential treatment with 0.1% bacterial collage-
nase (wt/vol) plus 0.1% dispase (wt/vol), and 0.5% trypsin (wt/vol),
washed, resuspended in 
 
a
 
MEM with or without Flt-Fc, and seeded onto
type I collagen-–coated membranes of culture inserts (Sato et al., 1998).
These culture inserts were then placed in 12-well plates containing 
 
a
 
MEM
supplemented with 0.1% albumax, with or without VEGF as indicated.
After an overnight culture, the cells were stained for TRAP. Invasion was
determined by counting before and after removal of the cells from the up-
per surface of the membranes, thereby rendering visible only osteoclasts
or osteoclast extensions that had reached the lower surface of the mem-
brane (Sato et al., 1998). Invasion scores were determined by taking the
ratio of these two numbers. The scores of the different groups were com-
pared with the analysis of the variance with Scheffe’s 
 
F
 
 test.
 
Cartilage Degradation
 
6-mm cartilage discs were punched out of 10-d-old rabbit ears, devitalized,
and further processed as reported (Hauser and Vaes, 1978). They were
then placed in 96-well plates in 200 
 
m
 
l 
 
a
 
MEM containing up to 50 nM
MMP-13 and/or MMP-9 activated by 4-aminophenylmercuric acetate. The
molar concentrations of active MMP-13 and MMP-9 were determined by
active site titration with the tight-binding MMP inhibitor BB94 (Knight,
1995). The discs were incubated at 37
 
8
 
C under 5% CO
 
2
 
 for up to 24 h. Hy-
droxyproline was measured in the media after hydrolysis in saturated
Ba(OH)
 
2
 
 (Bergman and Loxley, 1963). Under these conditions, hydroxy-
proline in the media increased linearly with incubation time.
 
Metatarsal Cultures with mFlt-IgG
 
Day 17 metatarsals (day of vaginal plug is designated as day 0) from wild-
type mice were dissected and cultured for 3 d on Nucleopore membrane
floating on 1 ml of BGJb culture medium supplemented with 10% fetal
calf serum. Control IgG or the mouse chimeric VEGF receptor mFlt-Ig
was added to a final concentration of 20 
 
m
 
g/ml. The medium was changed
daily. After the culture, bones were fixed in 4% paraformaldehyde at 4
 
8
 
C
overnight and processed for paraffin sections.
 
Results
 
Analysis of the Effect of MMP-9 Deficiency on
Bone Resorption
 
MMPs are rate-limiting for bone resorption in cultures of
embryonic day (E)18 calvariae and E17 tibiae which are
rich in mature bone–resorbing osteoclasts and in cultures
of E17 metatarsals that lack mature osteoclasts, but de-
pend on recruitment of (pre)osteoclasts for resorption
(Delaissé et al., 1985; Hill et al., 1994; Blavier and De-
laissé, 1995; Everts et al., 1998). Osteoclasts and osteoclast
precursors express MMP-9 at a high level (Reponen et al.,
1994; Tezuka et al., 1994; Blavier and Delaissé, 1995;
Okada et al., 1995). Therefore, we used MMP-9
 
2/2
 
 mice to
investigate the effect of MMP-9 deficiency in these calva-
ria, tibia, and metatarsal bone resorption models (Fig. 1).
The absence of MMP-9 did not affect the demineralization
rates of the calvariae and tibiae, but did reduce demineral-
ization of metatarsals to 30% of the values found in the
MMP-9–positive
 
 
 
controls. These data suggest that MMP-9
deficiency affects resorption of calcified skeletal elements
only in situations where osteoclast recruitment is a prereq-
uisite for resorption.
We compared the sensitivity of resorption of MMP-
9–positive
 
 
 
and MMP-9–deficient bones to various inhibi-
tors of proteinases reported to be rate-limiting for resorp-
tion (Fig. 2). E-64, a cysteine proteinase inhibitor, reduced
resorption of tibiae to similar levels in MMP-9–positive
and MMP-9–deficient bones. These results suggest that
the absence of effect of MMP-9 deficiency on resorption is
not due to compensation by cysteine proteinases. A gen-
eral MMP inhibitor produced 50% inhibition in the tibiae,
and close to 100% in the metatarsal cultures, in accor-
dance with our previous report that MMP activity is in-
volved in resorption but is more critical for osteoclast
recruitment (Blavier and Delaissé, 1995). These levels of
inhibition were not influenced by MMP-9 deficiency.
MMP-9 deficiency did not affect either the levels of other
MMPs in extracts of freshly isolated or cultured calvariae,
tibiae, and metatarsals or in their conditioned medium, as
far as can be detected by gelatin/casein zymography (not
shown). We interpret these data to indicate that MMPs
other than MMP-9 are involved in resorption of calcified
tissue itself and suggest that, instead, MMP-9 may play a
role in osteoclast recruitment. 
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Parallel Changes in MMP-9 and Osteoclast Activities at 
Early Stages of Bone Development
 
We next evaluated the expression of MMP-9 at critical
steps of osteoclast recruitment. We analyzed metatarsals of
 
mouse embryos at three well characterized developmental
stages (Scheven et al., 1986): (a) at E15 and E16, when os-
teoclast precursors and endothelial cells are in the mesen-
chyme surrounding the bone rudiments well before the
presence of a marrow cavity and of mature osteoclasts; (b)
at E17, when the osteoclast precursors become TRAP
 
1
 
;
and (c) at E18, when they invade into the bone together
with endothelial cells and differentiate into mature osteo-
clasts that resorb the calcified cartilage of the core of the di-
aphysis. When we analyzed extracts of these metatarsals at
these different developmental stages by zymography (Fig.
3), we detected MMP-9 zymogen as a faint band at E15 and
E16, and as a strong band at E17. At E18 we detected two
bands corresponding to zymogen and active forms. Thus
the changes in MMP-9 levels and activation state occur
concomitantly with invasion of TRAP
 
1
 
 cells into the bone
rudiment. MMP-2 levels changed less dramatically during
this period although a higher proportion of activated
MMP-2 was found with increasing development.
We then localized MMP-9 mRNA and protein in these
metatarsals, and compared their localization to (pre)osteo-
clasts and endothelial cells, the cell types showing invasive
activity. We identified these cells by staining them for
TRAP and CD34, respectively. We prepared sets of adja-
cent sections stained for TRAP/CD34, and MMP-9 mRNA
or MMP-9 immunoreactivity (Fig. 4). We detected MMP-9
at E17, the developmental stage at which the osteoclast pre-
cursors become TRAP
 
1
 
 (Scheven et al., 1986). The analysis
of the adjacent sections showed that the strong MMP-9
mRNA and protein signals were restricted to TRAP
 
1
 
 cells,
and did not correspond to endothelial cells. Therefore, the
major source of MMP-9 in primitive metatarsals that are
about to undergo invasion at E17 is the (pre)osteoclasts.
These observations show that there is a close spatial-tempo-
ral correlation between MMP-9 and invasion of the osteo-
clasts into the core of the developing bones.
 
Histomorphometric Analysis of the Effect of MMP-9 
Deficiency on Osteoclast Recruitment
 
To investigate whether MMP-9 is actually required in this
invasion process, and to characterize its role in osteoclast
recruitment by direct observations, we analyzed the effect
of MMP-9 deficiency on the numbers and distribution of
Figure 1. Effect of MMP-9 deficiency
on the resorption of different types of
bones. Calvariae of E18 embryos and
tibiae and metatarsals of E17 embryos
were obtained from two and eight lit-
ters, respectively, of heterozygote par-
ents. The embryos were phenotyped as
MMP-9–positive (circles) or MMP-9–neg-
ative  (triangles). The bone explants
were cultured for the indicated times.
Each point shows the mean 6 SD of
45Ca release determined in independent
cultures of 41 MMP-9–positive and 23
MMP-9–negative metatarsals or tibiae,
or 9 MMP-9–positive and 4 MMP-9–neg-
ative calvariae. Significant differences in
45Ca release from MMP-9–positive and
MMP-9–negative explants were seen
only for the metatarsals (P , 0.05).
Figure 2. Effect of proteinase inhibitors on the resorption of meta-
tarsals and tibiae. Tibiae and metatarsals of E17 embryos were ob-
tained from three (A) or five (B) litters of heterozygote parents. The
embryos were phenotyped as MMP-9–positive (circles) or MMP-
9–negative (triangles). The bone explants were cultured in the
absence (filled symbols) or presence (corresponding open symbols)
of 2.5 mM BB94 (A) or of 48 mM E64 (B). Each point shows the
mean 6 SD of 45Ca release determined in 14 independent cultures
of MMP-9–positive and 12 independent cultures of MMP-9–nega-
tive explants, each with and without BB94 (A), or in 29 independent
cultures of MMP-9–positive and 12 independent cultures of MMP-
9–negative explants, each with and without E-64 (B). All the inhibi-
tors significantly inhibited 45Ca release, with the exception of E64 on
MMP-9–negative metatarsals after 2 d of culture (P , 0.05). 
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TRAP
 
1
 
 cells and their nuclei in the metatarsals of E17,
E18, and E19 embryos (Fig. 5). At E17, there were only a
few TRAP
 
1
 
 cells in the mesenchyme surrounding the
bone, and none of them had invaded the calcified cartilage
in agreement with earlier reports on the wild-type mice
(Blavier and Delaissé, 1995). We did not detect differ-
ences between MMP-9–positive and MMP-9–negative
bones with respect to number, size, and distribution of
TRAP
 
1
 
 cells. Thus, there is no indication that MMP-9 has
an obligatory role in the differentiation of preosteoclasts
into TRAP
 
1
 
 cells before bone invasion.
At E18 and E19, MMP-9–positive bones (
 
1
 
/
 
2
 
 from
MMP-9
 
1
 
/
 
2
 
 
 
3 
 
MMP-9
 
2
 
/
 
2
 
 matings) showed the typical fea-
tures of recruitment of TRAP
 
1
 
 cells (Blavier and De-
laissé, 1995). Thus, the total numbers of nuclei increased
up to three and four times the values found at E17, in
agreement with the concept that there is a continuous dif-
ferentiation of TRAP
 
2
 
 precursors into TRAP
 
1
 
 
 
cells. At
the same time there was a dramatic shift in the distribu-
tion of TRAP
 
1
 
 cells from the surrounding mesenchyme
into the calcified core of the diaphysis. From E17 to E18
and E19, the proportion of nuclei in the core of the dia-
physis increased from 0 to 81% and 98%, respectively.
During this invasion, the TRAP
 
1
 
 cells fused progressively
into multinucleated osteoclasts that resorbed the septae of
the calcified cartilage, and transformed the core of the
bone into a “marrow” cavity.
MMP-9
 
2/2
 
 bones from embryos of the same litter and of
the same age differed from these MMP-9
 
1
 
/
 
2
 
 bones mainly
in two respects. First, the increase in the number of nuclei
of TRAP
 
1
 
 cells was only 70% of that of MMP-9
 
1
 
/
 
2
 
 bones
(Fig. 5). The average number of nuclei per osteoclast, how-
Figure 3.  Gelatin zymography of extracts of metatar-
sals at different developmental stages. Metatarsal tri-
ads were isolated from four mouse embryos at E15,
E16, E17, and E18. Extracts were obtained and ana-
lyzed by zymography as explained in Materials and
Methods. Each lane is representative of one embryo.
Pro–MMP-9 and Pro–MMP-2 are the zymogens of
MMP-9 and MMP-2, respectively.
Figure 4.  In situ hybridiza-
tion and immunostaining of
MMP-9 in sections of diaphy-
sis of developing metatarsals.
Two sets of adjacent sections
of E17 metatarsals were pre-
pared (A, B and C, D). In
each set, one section was
hybridized with antisense
MMP-9 probe (A), or immu-
nostained for MMP-9 (C);
their respective adjacent sec-
tions were stained both for
CD34 immunoreactivity and
TRAP activity (B and D).
Strong hybridization signals
(A) and MMP-9 immunore-
activity (C) are seen outside
the calcified cartilage (cc)
(arrows). Signals for TRAP
activity (red) in the adjacent
sections (B and D) (arrows)
correspond to the localiza-
tions of the MMP-9 hybrid-
ization (A) and immuno-
reactivity (C) signals,
respectively. CD34 signals
(brown) (B and D) are abun-
dant in the periosteal cell
layer (po) and do not have
clearly matching MMP-9 hy-
bridization (A) or immu-
noreactivity signals (C).
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ever, was not affected (Fig. 6). This observation suggests
that the lack of MMP-9 does not affect cell fusion. Second,
and more importantly, MMP-9 deficiency resulted in a de-
layed invasion of TRAP1 cells into the calcified cartilage
(Figs. 5 and 7). At E18 and E19, the proportions of nuclei
in the calcified cartilage were 20 and 40%, respectively, of
those in MMP-9–positive bones. The osteoclasts of the
MMP-9–negative bones tended then to accumulate at the
interface between the osteoid (i.e., unmineralized col-
lagen) of the bone collar and the calcified cartilage. During
this period, the distribution of endothelial cells inside and
outside the calcified cartilage was closely coordinated with
that of TRAP1 cells, whether MMP-9 was lacking or not.
Endothelial cells appeared inside the calcified cartilage
only when TRAP1 cells had invaded the calcified cartilage
(Fig. 7). Thus, the main result of MMP-9 deficiency was an
impaired migration of TRAP1 cells and endothelial cells
from the periosteum to the calcified cartilage.
Effect of MMP-9 Deficiency on Invasion of Type I 
Collagen by Osteoclasts
When the TRAP1 cells migrate from the periosteum to
the calcified cartilage, they must overcome a barrier of un-
mineralized bone matrix, called osteoid, that comprises
mainly type I collagen (Blavier and Delaissé, 1995). Mi-
gration of osteoclasts through type I collagen is inhibited
by a general MMP inhibitor (Sato et al., 1998). To evaluate
whether MMP-9 is critical for migration of osteoclasts
through collagen, we compared migration rates of MMP-
9–positive and MMP-9–negative osteoclasts through col-
lagen-coated membranes. A general MMP inhibitor
strongly blocked invasion of both phenotypes to the same
extent. However, MMP-92/2 osteoclasts were not signifi-
cantly less invasive (Fig. 8). These data indicate that a me-
talloproteinase (or metalloproteinases) different from
MMP-9 is critical for the invasive activity of osteoclasts
into collagen.
Effect of MMP-9 on Solubilization of Cartilage
To determine whether the delayed invasion into cartilage
relates to a role of MMP-9 in cartilage solubilization, we
investigated the effect of MMP-9 on cartilage degradation
in the presence and absence of MMP-13 (collagenase-3),
an MMP that is highly expressed by the hypertrophic
chondrocytes at this developmental stage (Blavier and De-
laissé, 1995) and strongly binds to collagen (Gillet et al.,
1977; Delaissé et al., 1993). We found that MMP-9 ren-
dered the collagenolytic activity of MMP-13 twice as effi-
cient, but had almost no collagenolytic activity by itself
(Table I). This collagenolysis-enhancing effect of MMP-9
may favor the penetration of the cells into the cartilage
core of the diaphysis.
Role of VEGF in the Recruitment of Osteoclasts
At the growth plate, hypertrophic cartilage expresses
VEGF, and inhibition of VEGF activity blocks the recruit-
Figure 5.  Effect of MMP-9 deficiency on number and distribu-
tion of TRAP1 cells in developing metatarsals. Litters of E17,
E18, and E19 embryos were obtained from MMP-91/2 and
MMP-92/2 parents. The embryos were genotyped as MMP-91/2
or MMP-92/2. Metatarsal triads were analyzed with respect to
number of nuclei of TRAP1 cells localized outside or inside the
calcified cartilage. Means 6 SD were calculated for each age
group and genotype. Total numbers of embryos were as follows:
at E17, 12 MMP-91/2 and 11 MMP-92/2 (pool of 3 litters); at E18,
31 MMP-91/2 and 20 MMP-92/2 (pool of 7 litters); and at E19, 9
MMP-91/2 and 8 MMP-92/2 (pool of 3 litters). Mean counts out-
side the calcified cartilage are shown by a block to the left of the
zero axis, and mean counts inside the calcified cartilage by a
block to the right. Each horizontal bar resulting from the align-
ment of these two blocks represents the mean number of total
nuclei in one section of a metatarsal triad. At E18 and E19,
MMP-92/2 and MMP-91/2 metatarsals differed significantly with
respect to both total number of nuclei of TRAP1 cells and their
proportion in the calcified cartilage (P , 0.05). In contrast, at
E17 no significant differences were found.
Figure 6.  Effect of MMP-9
deficiency on number of nu-
clei per TRAP1 cell. The
number of nuclei per TRAP1
cell were calculated from the
counts of cells and nuclei
shown in Fig. 5, and are
shown as mean 6 SD.
Table I. Effect of MMP-9 on Solubilization of Type II Collagen 
from Cartilage
Additive Collagen solubilized
%*
MMP-9 19 6 4
MMP-13 100
MMP-9 1 MMP-13 219 6 7
MMP-9 1 MMP-13 1 GM6001 6 6 2
Cartilage discs were incubated for 12 or 24 h in the presence of 50 nM of the indicated
MMP. The concentration of MMP inhibitor GM6001 was 10 mM. Collagen
solubilizations were normalized to the levels obtained in the presence of MMP-13
(average of 19.7 nmol hydroxyproline per 24 h), and are shown as means 6 SD of three
independent incubations.
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ment of MMP-9–positive and TRAP1 cells (Gerber et
al., 1999). We found that hypertrophic cartilage of E17
metatarsals, before osteoclast recruitment, also expressed
VEGF. There were no differences in VEGF expression in
MMP91/2 or MMP-92/2 metatarsals (Fig. 9 A). To deter-
mine the role of VEGF in the recruitment of osteoclasts
into the hypertrophic cartilage, we blocked VEGF activity
in cultures of E17 metatarsals. Metatarsals cultured for 3 d
in the presence of a soluble VEGF receptor, mFlt-IgG,
showed very few TRAP1 cells inside the hypertrophic car-
tilage. This inhibition was not as complete as that produced
by a broad spectrum MMP inhibitor, as was also seen for
MMP-92/2 metatarsals. In contrast, those metatarsals cul-
tured in the presence of a control IgG of the same isotype
showed extensive invasion of TRAP1 cells into hyper-
trophic cartilage (Fig. 9 B). These data show that VEGF is
involved in (pre)osteoclast recruitment in the core of the
diaphysis, similar to that in the growth plates.
To further explore whether VEGF acts directly on os-
teoclasts and exerts chemotactic activity, we seeded osteo-
clasts differentiated from bone marrow precursors in vitro
in the upper chamber of culture inserts with collagen-
coated membranes, and determined their migration to the
lower surface of the membranes in the presence of increas-
ing concentrations of VEGF in the lower chamber. VEGF
stimulated migration of the cells (Fig. 10). This effect of
VEGF was abolished by addition of hFlt-Fc to the upper
chamber. These observations show that VEGF can act di-
rectly on osteoclasts and is chemotactic for them.
Discussion
The development of the skeleton requires targeting of the
destructive activity of the osteoclast to specific sites of the
bone. Proteinases and local factors play an important role
in regulating this process, but their identity and their mode
of action have not been determined. Our work shows that
MMP-9 from osteoclast and/or osteoclast-like cells plays
an important role in inducing and expanding the primitive
marrow cavity of long bones. This role is a permissive
function to facilitate osteoclast invasion into the cartilagi-
nous core of the bone rudiments, rather than an involve-
ment in removal of mineralized matrix. Other MMPs are,
however, critical at other stages of the recruitment pro-
cess. Also, we show that VEGF is among the rate-limiting
factors inducing the formation of the primitive marrow
cavity and is a chemoattractant for osteoclasts. This indi-
cates that endothelial cells are not the only cell type medi-
ating VEGF-induced cartilage invasion. Since MMP-9 is
able to release ECM-bound VEGF (Bergers et al., 2000),
our findings suggest an integrated action of MMP-9 and
VEGF in skeletal development.
MMP-9 Is Not Involved in Solubilization of Mineralized 
Matrix by Osteoclasts
Osteoclasts that resorb mineralized matrix typically are
polarized cells, forming a sealed-off resorption compart-
ment upon attachment onto the surface of the mineralized
matrix. Inhibitors of the cysteine proteinase cathepsin K
Figure 7. Sections through the diaphysis of MMP-9–positive and
MMP-9–negative metatarsals showing invasion and lack of inva-
sion, respectively, by (pre)osteoclasts and endothelial cells at E18.
Sections of MMP-9–positive (A) and MMP-9–negative (B) meta-
tarsals of E18 embryos were obtained as explained in Fig. 5 and
stained for TRAP activity and CD34 immunoreactivity to visual-
ize (pre)osteoclasts (red) and endothelial cells (brown), respec-
tively. MMP-9–positive metatarsals show large mature osteoclasts
and endothelial cells that have invaded calcified cartilage (cc).
MMP-9–negative metatarsals do not show osteoclasts or endothe-
lial cells in calcified cartilage, but show well (pre)osteoclasts in the
bone collar (bc). Endothelial cells are also abundant in the peri-
osteal cell layer (po) in both phenotypes. Bar, 50 mm.
Figure 8. Comparative effect
of MMP-9 deficiency and of a
general MMP inhibitor on os-
teoclast migration through
type I collagen. Osteoclasts of
MMP-9–positive and MMP-
9–negative mice were cultured
on collagen-coated filters in
the presence and absence of
10 mM GM6001 (average of
227 osteoclasts/filter). Their
invasion through the collagen was evaluated as explained in Materi-
als and Methods, and is shown as means 6 SD of three cultures.
*Significant effect compared with osteoclasts of MMP-9–positive
mice cultured without inhibitor (P , 0.05).The Journal of Cell Biology, Volume 151, 2000 886
and general MMP inhibitors inhibit collagen degradation
in this zone (Everts et al., 1998). The effect of MMP inhib-
itors coupled with the high expression of MMP-9 in osteo-
clasts led to the hypothesis that MMP-9 is the critical
MMP for bone matrix solubilization (Tezuka et al., 1994;
Okada et al., 1995). However, bone histology of the MMP-9
knockout mice does not reveal a lack of osteoclastic re-
sorption of mineralized matrix (Vu et al., 1998). In further
support of the lack of a role of MMP-9 in solubilization of
mineralized matrix, we show that specialized bone resorp-
tion models, which respond to general MMP inhibitors
(Delaissé et al., 1985; Hill et al., 1994; Blavier and De-
laissé, 1995) (see Fig. 2), have the same bone degradation
rates in MMP-9–negative and MMP-9–positive bones, even
when bone resorption was stimulated with bone resorbing
agents like parathyroid hormone and 1,25(OH)2D3. In cal-
variae, where MMPs have proved to be particularly impor-
tant for matrix solubilization (Everts et al., 1999), MMP-9
deficiency was without effect. Cathepsin K, which is very
efficient for matrix solubilization by osteoclasts (Saftig et
al., 1998), did not compensate for MMP-9 because a
cathepsin K inhibitor reduced resorption of tibiae to
similar levels in MMP-9–negative and MMP-9–positive
bones. Thus, the identity of the critical MMP involved in
matrix solubilization in the resorption zone remains to be
determined.
MMP-9 Is a Major MMP for Osteoclast Recruitment in 
Primitive Long Bones, and Is Specifically Required for 
the Passage of the Cells through Their
Osteoid–Cartilage Interface
The first destructive task of osteoclasts in primitive long
bones is the formation of the marrow cavity. Preosteo-
clasts are recruited into the bone from the surrounding
mesenchyme, a process that is completely inhibited by
general MMP inhibitors (Blavier and Delaissé, 1995). We
have now identified MMP-9 as a major MMP for this re-
cruitment process. This role of MMP-9 is also supported
by observations in bones of wild-type mice, since there is
an excellent correlation between MMP-9 and invasion of
osteoclasts into the core of the diaphysis. However, MMPs
distinct from MMP-9 also participate in this recruitment,
since the inhibition induced by the absence of MMP-9 is
only partial whereas the inhibition generated by general
MMP inhibitors is complete.
Figure 9. Effect of blocking VEGF ac-
tivity on recruitment of TRAP1 cells
into developing metatarsals. (A) Dark
field photographs of sections of E17
wild-type (1/1) and MMP-9 null
(MMP-92/2) metatarsals hybridized
with a 35S-labeled VEGF antisense
probe. (B) Adjacent sections of meta-
tarsals cultured for 3 d in control IgG
or mFlt-IgG stained with hematoxylin
and eosin (upper panels) or for TRAP
activity (lower panels). Bars, (A) 200
mm; (B) 320 mm.Engsig et al. MMP-9 and VEGF in Osteoclast Invasion 887
The biological events required by this recruitment are
the generation of preosteoclasts in the mesenchyme sur-
rounding the bone, their maturation, and their migration
into the core of the diaphysis. It is clear that the main role
of MMP-9 (and/or other MMPs) relates to the latter mi-
gration because lack of MMP-9 (or of MMP activity) leads
to an accumulation of TRAP1 cells around the diaphysis,
and does not prevent the formation of multinucleated
cells. The generation of TRAP1 cells in E18 and E19 in
the absence of MMPs is somewhat smaller (Blavier and
Delaissé, 1995; this work). This may be due to the modu-
lating effect that resorption may exert on the recruitment
of new osteoclasts (Van De Wijngaert et al., 1988), or to
decreased VEGF bioavailability which may participate in
osteoclast differentiation (Niida et al., 1999).
There are several critical steps along the migration route
of the TRAP1 cells. The preosteoclasts must leave the pe-
riosteal cell layer, move through a 12–25-mm seam of os-
teoid whose inner edge is slightly and discontinuously min-
eralized, and finally invade the outer cartilage septae that
are also discontinuously mineralized (Blavier and Delaissé,
1995). In the absence of MMP-9, the TRAP1 cells tend to
accumulate at the osteoid–cartilage interface, suggesting
that their movement through osteoid is not affected. Ex-
periments with type I collagen gels in invasion chambers
confirmed that the intrinsic ability of osteoclasts to move
through collagen is not significantly affected by the ab-
sence of MMP-9. This is in contrast to the effects of general
MMP inhibitors, which block the migration of the (pre)os-
teoclasts through osteoid in E17 metatarsals (Blavier and
Delaissé, 1995) or through type I collagen in invasion
chambers (Sato et al., 1998; this study). This shows that
other (or another) MMPs are especially important for the
migration through osteoid, which involves only focal lysis
(Blavier and Delaissé, 1995). A good candidate is MT1-
MMP, a membrane-bound collagenolytic proteinase that
has been identified in invadopodia and at the leading edge
of moving osteoclasts (Sato et al., 1997). MT1-MMP null
mice show bone and cartilage defects that have not been
investigated in detail (Holmbeck et al., 1999).
What Is the Molecular Mode of Action of MMP-9 for 
Cartilage Invasion?
Our data are compatible with several molecular modes of
action of MMP-9 in cartilage invasion. First, MMP-9 may
speed up cartilage solubilization. This is interesting be-
cause such proteolytic action is required exactly at the
point of the migration route where MMP-9 becomes nec-
essary. At E17 this cartilage matrix is discontinuously
mineralized (Blavier and Delaissé, 1995). The classical re-
sorptive machinery of the osteoclast is responsible for
solubilizing the mineralized cartilage, as shown by the ef-
fects of classical inhibitors of their resorptive activity, in-
cluding bisphosphonates and cysteine proteinase inhibi-
tors (Blavier and Delaissé, 1995). In contrast, these
inhibitors do not inhibit invasion of the osteoclasts into the
core of the diaphysis, and this invasion largely proceeds by
passage through nonmineralized septae (Blavier and De-
laissé, 1995). Since this passage requires MMP-9, it ap-
pears that the role of MMP-9 relates to solubilization of
nonmineralized septae. This is reminiscent of cartilage in-
vasion at the growth plate: the transversal septae are non-
mineralized and their invasion does not require resorptive
activity of osteoclasts (Schenk et al., 1967), but requires
MMP-9 (Vu et al., 1998). MMP-9 is present at the edge of
the last transversal septa and in debris of type II collagen
at various states of digestion (Vu et al., 1998; Lee et al.,
1999). Our test tube assays show that MMP-9 stimulates
unmineralized cartilage degradation in the presence of
MMP-13. Interestingly, MMP-13 is highly expressed in the
hypertrophic chondrocytes filling the diaphysis of embry-
onic metatarsals, as well as in the growth plates (Blavier
and Delaissé, 1995; Gack et al., 1995), and binds cartilage
septae (Lee et al., 1999). It has been proposed that MMP-9
and MMP-13 cooperate for degrading the unmineralized
cartilage of these septae (Lee et al., 1999). Our experi-
ments provide direct support to this hypothesis. One may
speculate that MMP-9 speeds up the degradation of pro-
teoglycans, thereby rendering the collagen more accessible
for degradation by MMP-13. Alternatively, MMP-9 may
promote the digestion of the collagen that was destabilized
by the attack of MMP-13. However, it is unclear to what
extent the effect of MMP-9 on collagenolysis is essential
for cartilage invasion, since cartilage invasion at the sec-
ondary site of ossification is only minimally affected by the
lack of MMP-9 (Vu et al., 1998), although this invasion
also requires breaching of cartilage septae. Both MMP-9
and MMP-13 are normally expressed at these sites (De-
laissé, unpublished results).
Second, MMP-9 may favor cartilage invasion by releas-
ing growth and differentiation factors. Proteolytic release
of matrix-bound components from E17 metatarsals and
growth plates appears to be involved in recruitment of
TRAP1 cells and endothelial cells, respectively (Van De
Wijngaert et al., 1988; Vu et al., 1998). Among the factors
affecting osteoclast recruitment in both growth plate and
E17 metatarsals are M-CSF (Felix et al., 1990; Hofstetter et
al., 1995; Jemtland et al., 1998), TGF-b (Dieudonné et al.,
1991), and VEGF (Gerber et al., 1999). That active TGF-b
and VEGF are made bioavailable by MMP-9 (Bergers et
al., 2000; Yu and Stamenkovic, 2000) may be particularly
relevant to the recruitment process. VEGF function is re-
quired in growth plate invasion (Gerber et al., 1999) and di-
aphysis invasion (this work); however, it is absent at the
secondary site of ossification of the epiphysis (Werb, un-
published results) where the role of MMP-9 is also less im-
portant (Vu et al., 1998). A hypothesis that unifies these
observations is that the major mode of action of MMP-9 is
to make VEGF functional as a chemoattractant and pro-
mote invasion.
Figure 10. Effect of VEGF
on osteoclast migration. Os-
teoclasts were cultured over-
night on collagen-coated
membranes of culture in-
serts (average of 1,032 osteo-
clasts/insert). These inserts
were placed in 12-well plates
containing the indicated con-
centration of VEGF. 100 ng/
ml Flt-1/Fc was added to the
culture inserts where indicated. The migrations were scored as
explained in Materials and Methods, and are shown as mean 6
SD of four cultures. *Significant effect compared with osteoclasts
cultured without additive (P , 0.05).The Journal of Cell Biology, Volume 151, 2000 888
Still other modes of action of MMP-9 in diaphysis inva-
sion are possible. Several molecules appear to be positioned
at the osteoid–cartilage interface, i.e., precisely at the site
where MMP-9 becomes important. These include mole-
cules with strong effects on cell motility, such as transferrin,
bone sialoprotein, osteopontin, and osteonectin (Gentili et
al., 1994; Sommer et al., 1996). Interestingly, MMP-9
cleaves osteopontin and osteonectin molecules in their
functional domain (Sasaki et al., 1997; Delaissé, unpub-
lished results). The adhesive properties of osteopontin are
strongly affected by this fragmentation (Senger et al., 1994;
Xuan et al., 1994). Finally, osteoclasts express CD44 (Naka-
mura et al., 1995), an adhesion molecule with a strong affin-
ity for hyaluronic acid that is abundant in cartilage. Hyal-
uronic acid may induce clustering of CD44 and MMP-9 on
their plasma membrane, thereby promoting invasiveness, as
reported for cancer cells (Yu and Stamenkovic, 1999).
Relative Importance of Osteoclasts, Chondroclasts, and 
Endothelial Cells in Cartilage Invasion
Several cell types that are able to express MMP-9 are
present in the area of the invasion front of the growth
plate. They include endothelial cells, chondroclasts, and
osteoclasts. Chondroclasts refer to the cells against the
nonmineralized transversal septae, whereas osteoclasts re-
fer to cells along the mineralized longitudinal trabeculae
(Vu et al., 1998). These two cell types show inverse
amounts of MMP-9 and TRAP at early developmental
stages, chondroclasts being richer in MMP-9 and poorer in
TRAP (Jemtland et al., 1998). Moreover, chondroclasts do
not form a ruffled border to the same extent as typically
polarized, resorbing osteoclasts (Nordahl et al., 1998). We
did not detect distinct osteoclast and chondroclast popula-
tions in diaphysis invasion. This may be due to the random
distribution of mineralized and nonmineralized portions
of cartilage in the primitive diaphysis (Blavier and De-
laissé, 1995), in contrast to the situation in the growth
plate (Schenk et al., 1967). At least some chondroclasts
may derive from a cell lineage other than osteoclasts, be-
cause MMP-9–positive cells are present and growth ossifi-
cation takes place in osteopetrotic mice (Fos2/2; Grigoria-
dis et al., 1994). However, osteoclasts can exhibit distinct
phenotypes depending on their microenvironment, such as
mineral (Gravallese et al., 1998), and distinct osteoclast ac-
tivities do require functional and structural reorganiza-
tions, typical of epithelial–mesenchymal transitions (Na-
kamura et al., 1996). In particular, the polarized resorbing
osteoclast secretes the cysteine proteinase cathepsin K
into the acidic resorption zone to solubilize the mineral-
ized matrix, whereas the rounded, nonpolarized osteo-
clasts depend on MMPs and not on cysteine proteinases
for migration in nonmineralized collagen (Sato et al.,
1998). The nonpolarized osteoclast-related cell that in-
vades nonmineralized cartilage in the growth plate and di-
aphysis depends on MMP-9 for this invasion (Vu et al.,
1998; this work).
Another important question is the identity of the target
cells of the VEGF. VEGF effects have often been inter-
preted in the context of chemotaxis on endothelial cells.
However, osteoclasts express VEGF receptor 1 (Flt-1),
and VEGF can support osteoclast generation (Niida et al.,
1999). Our work also shows that VEGF acts directly on os-
teoclasts and promotes their invasive activity. The fact that
both endothelial cells and osteoclasts are responsive to
VEGF fits well the observation that invasion of the di-
aphysis of the primitive metatarsals is approximately si-
multaneous for both cell types. Through these mechanisms
VEGF serves to coordinate ECM degradation and recruit-
ment of endothelial cells and osteoclasts.
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